News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
See what our post-Journal Club happy hour looks like! – Roswell Park Hematology/Oncology Fellowship Program
Photo from Roswell Park Hematology/Oncology Fellowship Program/X
May 9, 2024, 10:45

See what our post-Journal Club happy hour looks like! – Roswell Park Hematology/Oncology Fellowship Program

The Roswell Park Hematology/Oncology Fellowship Program shared on X:

“See what our post-Journal Club happy hour looks like! Ben Switzer, our dearest former Chief fellow, is nailing the attending game as melanoma doctor at Roswell Park.” .

Source: Roswell Park Hematology/Oncology Fellowship Program/X

Ben Switzer Melanoma post-Journal Club Roswell Park Roswell Park Hematology/Oncology Fellowship Program
Special Coverage
Science
Jan 3, 2025, 16:58
Emmanuel S. Antonarakis: The two faces of FOXA1 mutations in prostate cancers
Science
Jan 3, 2025, 16:56
Richa Shah: My Forever Paper
Science
Jan 3, 2025, 16:51
Melinda Bachini: Advancing Patient-Centered Care in Transplant Oncology
Blog
Jan 3, 2025, 16:48
The NCI Cellular Cancer Biology Imaging Research Program
Blog
Jan 3, 2025, 16:40
Call for nominations for 2025 Arthur M. Sutherland Award and Memorial Lecture - IPOS
Career
Jan 3, 2025, 16:33
Amy de Haar-Holleman started as a Clinical Professor at Free University of Brussels
Science
Jan 3, 2025, 16:25
Amivantamab Plus Lazertinib in Patients With EGFR-mutant NSCLC by Benjamin Besse et al.
Science
Jan 3, 2025, 16:22
Expert consensus statement on the peri-operative management of NSCLC by Stephanie Saw et al.
Science
Jan 3, 2025, 16:17
Iannis Aifantis: Our short review/discussion of the Comazzetto and Morrison Ascorbate deficiency
Blog
Jan 3, 2025, 16:13
Early registration for GU25 closes on January 8th - ASCO
Blog
Jan 3, 2025, 15:57
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC
Blog
Jan 3, 2025, 15:31
Gaia Griguolo: TOP1 Mutations are more frequent after treatment with ADCs